Clincosm LogoSign in Get a demo

stage iiib breast cancer

Showing 1 - 25 of 125
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Estrogen Receptor Negative, HER2/Neu Negative, Invasive Breast Carcinoma Trial in South Africa, United States (drug, other,

Active, not recruiting
Has Results
  • Estrogen Receptor Negative
  • +11 more
  • Mobile, Alabama
  • +1023 more
Dec 7, 2022

Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in Bellevue, Grand Island, Omaha (drug, other,

Active, not recruiting
  • Estrogen Receptor Negative
  • +15 more
  • Bellevue, Nebraska
  • +3 more
Nov 30, 2022

HER2-positive Breast Cancer, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor Trial in Seattle

Active, not recruiting
  • HER2-positive Breast Cancer
  • +8 more
  • pNGVL3-hICD vaccine
  • +6 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Nov 1, 2022

Stage IA Breast Cancer, Stage IB Breast Cancer, Stage IIA Breast Cancer Trial in United States (Telephone-Based Intervention,

Recruiting
  • Stage IA Breast Cancer
  • +7 more
  • Telephone-Based Intervention
  • +2 more
  • Goldsboro, North Carolina
  • +3 more
Oct 27, 2022

HER2 Positive Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer Trial in Palo Alto (Utomilumab, Trastuzumab,

Completed
Has Results
  • HER2 Positive Breast Carcinoma
  • +6 more
  • Palo Alto, California
    Stanford University, School of Medicine
Sep 22, 2022

Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Los Angeles (procedure, drug, other)

Terminated
  • Estrogen Receptor Positive
  • +16 more
  • Biopsy of Breast
  • +5 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Sep 22, 2022

Estrogen Receptor-positive Breast Cancer, Musculoskeletal Complications, Progesterone Receptor-positive Breast Cancer Trial in

Active, not recruiting
  • Estrogen Receptor-positive Breast Cancer
  • +9 more
  • Boston, Massachusetts
  • +1 more
Sep 9, 2022

Cancer Survivor, Early-Stage Breast Carcinoma, Stage 0 Breast Cancer Trial in Los Angeles, Baltimore, Boston (Educational

Active, not recruiting
  • Cancer Survivor
  • +9 more
  • Educational Intervention
  • +3 more
  • Los Angeles, California
  • +2 more
Jul 18, 2022

Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer Trial in

Terminated
Has Results
  • Estrogen Receptor-positive Breast Cancer
  • +7 more
  • Atlanta, Georgia
  • +2 more
Mar 10, 2022

Obesity, Stage IA Breast Cancer, Stage IB Breast Cancer Trial in Duarte (Dietary Intervention, Educational Intervention,

Active, not recruiting
  • Obesity
  • +7 more
  • Dietary Intervention
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Mar 17, 2022

HER2-positive Breast Cancer, Recurrent Breast Cancer, Stage IIA Breast Cancer Trial in Duarte, Lancaster, South Pasadena

Active, not recruiting
  • HER2-positive Breast Cancer
  • +9 more
  • pertuzumab
  • +3 more
  • Duarte, California
  • +2 more
Mar 17, 2022

Solid Tumor, Stage III Pancreatic Cancer, Stage IIIA Breast Cancer Trial in Atlanta (Carboplatin, Cisplatin, Palbociclib)

Active, not recruiting
  • Solid Neoplasm
  • +16 more
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Feb 28, 2022

Cancer Survivor, Stage 0 Breast Cancer, Stage IA Breast Cancer Trial in Columbus (Educational Intervention, Exercise

Completed
  • Cancer Survivor
  • +8 more
  • Educational Intervention
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 23, 2022

HER2 Negative Breast Carcinoma, Recurrent Breast Carcinoma, Stage IIIA Breast Cancer Trial in Seattle

Recruiting
  • HER2 Negative Breast Carcinoma
  • +6 more
  • CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
  • Laboratory Biomarker Analysis
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Feb 18, 2022

Inflammatory Breast Cancer, Invasive Ductal Breast Carcinoma, Invasive Lobular Breast Carcinoma Trial in New Brunswick, Salt

Active, not recruiting
  • Inflammatory Breast Cancer
  • +9 more
  • External beam radiation therapy
  • New Brunswick, New Jersey
  • +1 more
Jan 30, 2022

Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer Trial in Aurora (Omega-3 fatty acid, Celecoxib)

Active, not recruiting
  • Stage IA Breast Cancer
  • +6 more
  • Aurora, Colorado
    University of Colorado Cancer Center
Jan 14, 2022

HER2/Neu Negative, No Evidence of Disease, One or More Positive Axillary Nodes Trial in Seattle, Madison (Laboratory Biomarker

Active, not recruiting
  • HER2/Neu Negative
  • +10 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Seattle, Washington
  • +1 more
Jan 11, 2022

Benign Breast Tumor, Ductal Breast Carcinoma In Situ, Invasive Breast Carcinoma Trial in Boston, New York, Houston

Completed
Has Results
  • Benign Breast Neoplasm
  • +11 more
  • Docosahexaenoic Acid
  • Placebo
  • Boston, Massachusetts
  • +3 more
Dec 3, 2021

Febrile Neutropenia, Stage 0 Breast Cancer, Stage 0 Colorectal Cancer Trial in Puerto Rico, United States (Preventive

Completed
  • Febrile Neutropenia
  • +27 more
  • Preventive Intervention
  • +2 more
  • Jonesboro, Arkansas
  • +159 more
Dec 22, 2021

Healthy, no Evidence of Disease, Stage II Breast Cancer, Stage IIIA Breast Cancer Trial in Los Angeles (light-scattering

Terminated
  • Healthy, no Evidence of Disease
  • +4 more
  • light-scattering spectroscopy
  • Los Angeles, California
    USC Norris Comprehensive Cancer Center
Nov 11, 2021

BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Ductal Breast Carcinoma in Situ Trial in Los Angeles (dietary supplement, other,

Active, not recruiting
  • BRCA1 Mutation Carrier
  • +8 more
  • soy isoflavones
  • +7 more
  • Los Angeles, California
    University of Southern California
Nov 11, 2021

Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer Trial in New

Suspended
  • Estrogen Receptor-negative Breast Cancer
  • +8 more
  • pegylated liposomal doxorubicin hydrochloride
  • +6 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Sep 20, 2021

Stage III Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer Trial in Nashville (Atezolizumab, Cobimetinib,

Terminated
Has Results
  • Stage III Breast Cancer
  • +6 more
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Aug 10, 2021

Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Invasive Ductal Breast Carcinoma Trial in Puerto Rico,

Active, not recruiting
  • Estrogen Receptor-positive Breast Cancer
  • +8 more
  • Birmingham, Alabama
  • +859 more
Jul 19, 2021

Inflammatory Breast Cancer, Stage IIA Breast Cancer, Stage IIIA Breast Cancer Trial in Duarte, South Pasadena (carboplatin,

Active, not recruiting
  • Inflammatory Breast Cancer
  • +9 more
  • Duarte, California
  • +1 more
Jul 9, 2021